Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.03.07.710099

The React & Rebound Model: Capturing Emotion Regulation Dynamics from Passive Wearable Data

Abstract

BackgroundEmotion regulation--the ability to respond to and restore equilibrium after emotional perturbations--is central to mental health. Yet objective measurement remains limited to lab-based studies with group-level results, while consumer wearables focus on physical activity-related metrics rather than emotional dynamics. ObjectiveWe aimed to develop computational models that extract personalized, interpretable emotion regulation parameters from continuous heart rate variability (HRV) data collected via consumer wearables during everyday life, and validate these parameters against self-reported anxiety symptoms. MethodsWe analyzed 4 weeks of continuous HRV data from N = 49 healthy adults wearing Samsung Galaxy Active 2 smartwatches. We derived a continuous autonomic balance signal and developed three computational modeling approaches of increasing sophistication: (1) a static sympathetic load metric, (2) an Ornstein-Uhlenbeck (OU) dynamical systems model capturing continuous restoration dynamics, and (3) a discrete-state Markov transition model--the React & Rebound model-- capturing reactivity and rebound dynamics. All models were estimated using joint hierarchical Bayesian models that simultaneously extract subject-specific parameters from HRV time series and estimate their association with Generalized Anxiety Disorder 7-item scale (GAD-7) scores. The validity of extracted parameters was evaluated against anxiety symptom severity. ResultsStatic sympathetic load correlated modestly with GAD-7 (r = 0.39, R2 = 0.16). The OU model captured 69% of variance (R2 = 0.69), and the React & Rebound model captured 60% (R2 = 0.60) with substantially fewer parameters. Both models revealed that anxiety symptom severity is associated with the interaction between activation and restoration parameters--not either alone. Fast rebound appeared protective even for highly reactive individuals, who scored comparably to low-reactivity groups when restoration was rapid (Cohens d = 1.17 between highest- and lowest-risk quadrants). In the OU model, the interaction effect was specific to GAD-7 scores versus PHQ-9 and ISI scores; in the React & Rebound model, the interaction was credible across all three symptom measures. Both models were unchanged after controlling for physical activity ({Delta}R2 < 0.002). ConclusionsComputational models can extract interpretable emotion regulation parameters from naturalistic wearable data. The React & Rebound model yields two personalized parameters--reactivity and rebound--that are strongly associated with anxiety symptoms and define meaningful autonomic profiles. These parameters bridge autonomic dynamics measurable via consumer devices to neural circuit models of emotion regulation, with implications for characterizing individual autonomic profiles via consumer wearables.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Heusser, A. C., Simon, T. J., Elliot, E., James, C., Gazzaley, A., Gibson, N.. 2026-03-10. The React & Rebound Model: Capturing Emotion Regulation Dynamics from Passive Wearable Data. https://doi.org/10.64898/2026.03.07.710099

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗